Tilak Mandadi is executive vice president, ventures and chief experience and technology officer at CVS Health®. In this role, Tilak is responsible for customer engagement and research, integrated service operations and reimagining health care experiences. He leads the company’s AI, technology and insights strategies and products powering business operations and growth. Tilak also heads CVS Health Ventures, a leading investment platform driving financial and strategic value for the enterprise.
Previously, he was executive vice president of digital, and chief technology officer at Disney, where he oversaw a global team of digital, data, operations, technology, creative and product professionals. His team was responsible for serving more than 150 million annual guests and consumers worldwide across Disney theme parks, hotels, cruise ships, retail stores, restaurants, Disney Vacation Club properties and the Adventures by Disney travel businesses.
Prior to Disney, Tilak led global Digital Transformation, including cards, consumer travel and banking, at American Express.
Over the course of his executive career, Tilak has very successfully led innovative startups as well as large global organizations across different industries and diverse cultures, including financial services, hospitality, travel and entertainment, retail, food and beverage, IT services and energy trading.
Tilak holds a master’s degree in computer science from the University of Oregon.
What is Tilak Mandadi's net worth?
The estimated net worth of Tilak Mandadi is at least $960.31 thousand as of May 8th, 2026. Mandadi owns 10,133 shares of CVS Health stock worth more than $960,315 as of May 12th. This net worth evaluation does not reflect any other assets that Mandadi may own. Learn More about Tilak Mandadi's net worth.
How do I contact Tilak Mandadi?
Has Tilak Mandadi been buying or selling shares of CVS Health?
Over the course of the past ninety days, Tilak Mandadi has sold $6,230,378.58 in CVS Health stock. Most recently, Tilak Mandadi sold 69,551 shares of the business's stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a transaction totalling $6,230,378.58. Following the completion of the sale, the executive vice president now directly owns 10,133 shares of the company's stock, valued at $907,714.14. Learn More on Tilak Mandadi's trading history.
Who are CVS Health's active insiders?
CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Anne Finucane (Director), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Michael Mahoney (Director), Tilak Mandadi (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Steven Nelson (EVP), Jonathan Roberts (COO), Guy Sansone (Director), Guy Sansone (Director), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?
In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,570 shares worth more than $100,009.00. In the last twelve months, insiders at the pharmacy operator sold shares 2 times. They sold a total of 77,051 shares worth more than $6,763,028.58. The most recent insider tranaction occured on May, 8th when EVP Tilak Mandadi sold 69,551 shares worth more than $6,230,378.58. Insiders at CVS Health own 0.9% of the company.
Learn More about insider trades at CVS Health. Information on this page was last updated on 5/8/2026.
